CD5 expression is an important feature of CLL B-cells and has been shown to inhibit BCR signaling and maintain tolerance in anergic B-cells after chronic (auto)antigenic stimulation (42) to limit autoantibody production. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.